Cargando…

Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome

OBJECTIVE: The aim of this study was to evaluate the impact of fecal donor-unrelated donor mix (FMT-FURM) transplantation as first-line therapy for C. difficile infection (CDI) in intestinal microbiome. METHODS: We designed an open, two-arm pilot study with oral vancomycin (250mg every 6 h for 10–14...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camacho-Ortiz, Adrián, Gutiérrez-Delgado, Eva María, Garcia-Mazcorro, Jose F., Mendoza-Olazarán, Soraya, Martínez-Meléndez, Adrián, Palau-Davila, Laura, Baines, Simon D., Maldonado-Garza, Héctor, Garza-González, Elvira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738078/ https://www.ncbi.nlm.nih.gov/pubmed/29261736 http://dx.doi.org/10.1371/journal.pone.0189768

Ejemplares similares

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
por: Garza-González, Elvira, et al.
Publicado: (2019)

Current knowledge on the laboratory diagnosis of Clostridium difficile infection
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2017)

Efficacy of computed tomography for the prediction of colectomy and mortality in patients with clostridium difficile infection
por: Paláu-Dávila, Laura, et al.
Publicado: (2016)

Increasing rates of Clostridium difficile infection in Mexican hospitals
por: Dávila, Laura Palau, et al.
Publicado: (2017)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2022)

502. Enhanced Sporulation and Vancomycin Resistance Associated With Clostridium difficile From Recurrent Infections
por: Tijerina-Rodriguez, Laura E, et al.
Publicado: (2018)

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

Draft genome sequences of two opportunistic pathogenic strains of Staphylococcus cohnii isolated from human patients
por: Mendoza-Olazarán, Soraya, et al.
Publicado: (2017)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
por: Camacho-Ortiz, Adrián, et al.
Publicado: (2015)

2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
por: Tijerina, Laura, et al.
Publicado: (2019)

Correction: First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
por: Camacho-Ortiz, Adrián, et al.
Publicado: (2015)

Transcriptomic analysis of biofilm formation in strains of Clostridioides difficile associated with recurrent and non-recurrent infection reveals potential candidate markers for recurrence
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry
por: Flores-Treviño, Samantha, et al.
Publicado: (2019)

Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico
por: Hernández-García, Raúl, et al.
Publicado: (2015)

Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection
por: Seekatz, Anna Maria, et al.
Publicado: (2016)

The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance
por: Bocanegra-Ibarias, Paola, et al.
Publicado: (2019)

Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood
por: Mendoza-Olazarán, Soraya, et al.
Publicado: (2015)

Rapid spread of an ongoing outbreak of Zika virus disease in pregnant women in a Mexican hospital
por: Garza-González, Elvira, et al.
Publicado: (2017)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection
por: Li, Xiaolu, et al.
Publicado: (2018)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022)

Advances in the Microbiome: Applications to Clostridium difficile Infection
por: Culligan, Eamonn P., et al.
Publicado: (2016)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016)

Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
por: Lin, Zayar, et al.
Publicado: (2020)

An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection
por: Antharam, Vijay C., et al.
Publicado: (2016)

Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis
por: Mintz, Michael, et al.
Publicado: (2018)

Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation
por: Pathak, Rahul, et al.
Publicado: (2013)

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
por: Borody, Thomas J., et al.
Publicado: (2015)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches
por: Lan, Nan, et al.
Publicado: (2017)

Correction: The carriage of interleukin-1B-31*C allele plus Staphylococcus aureus and Haemophilus influenzae increases the risk of recurrent tonsillitis in a Mexican population
por: González-Andrade, Baltazar, et al.
Publicado: (2017)

The carriage of interleukin-1B-31*C allele plus Staphylococcus aureus and Haemophilus influenzae increases the risk of recurrent tonsillitis in a Mexican population
por: González-Andrade, Baltazar, et al.
Publicado: (2017)

Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?
por: Reddymasu, Savio, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ahuvds3pus2gdo85nv43ffke7s